Longitude Venture Partners III, L.P.

CIK 1674099 · last filed 2022-04-21

Longitude Venture Partners III, L.P. is a corporate insider who has filed 3 SEC Form 4 insider transactions across 3 companies since 2020. The most recent filing shows the insider bought $20.0M of INZY on Apr 21, 2022. Across all open-market trades the lifetime net is +$20.0M, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

3

Lifetime Open-Market Net

$20.00M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Inozyme Pharma, Inc. (INZY) Delisted 10%+ Owner 4,174,379 $4.00 $16.70M $20.00M 1 2022-04-21
89bio, Inc. (ETNB) Delisted 10%+ Owner 2,080 $14.84 $30.9K $0 1 2020-11-18
Molecular Templates, Inc. (MTEM) Delisted 10%+ Owner 1,049 $0.00 $0 $0 1 2020-05-28

Recent Filings

3 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-04-21 Inozyme Pharma, Inc. (INZY) Delisted Buy (P) +5,420,000 $20.00M EDGAR
2020-11-18 89bio, Inc. (ETNB) Delisted Other (J) −3,376,224 $0 EDGAR
2020-05-28 Molecular Templates, Inc. (MTEM) Delisted Other (J) −3,972,036 $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.